Challenges of Establishing New Antithrombotic Therapies in Atrial Fibrillation

This publication has 31 references indexed in Scilit:

• Rationale and design of ACTIVE: The atrial fibrillation clopidogrel trial with irbesartan for prevention of vascular events
  American Heart Journal, 2006
• Translating the Results of Randomized Trials into Clinical Practice
  Stroke, 2006
• Use and Effectiveness of Warfarin in Medicare Beneficiaries With Atrial Fibrillation
  Stroke, 2006
• Trials and Tribulations of Non-Inferiority: The Ximelagatran Experience
  Journal of the American College of Cardiology, 2005
• Patient knowledge and perceptions of atrial fibrillation and anticoagulant therapy: Effects of an educational intervention programme
  International Journal of Cardiology, 2005
• The value of education and self‐monitoring in the management of warfarin therapy in older patients with unstable control of anticoagulation
  British Journal of Haematology, 2004
• Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial
  The Lancet, 2003
• The European regulatory experience
  Statistics in Medicine, 2002
• Equivalence and noninferiority trials
  American Heart Journal, 2000
• Canadian atrial fibrillation anticoaguiation (CAFA) study
  Journal of the American College of Cardiology, 1991